KIM CRUM: Open Payments
NPI 1811082589 · MARIETTA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,957 in 131 payments from 18 companies in 2025. Trend: 2023 $2,869 · 2024 $3,063 · 2025 $2,957
Food & beverage: $2,877Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $527 |
| UCB, Inc. | 14 | $371 |
| Eisai Inc. | 11 | $353 |
| Biogen, Inc. | 18 | $327 |
| Neurocrine BioSciences, Inc. | 9 | $192 |
| Lundbeck LLC | 8 | $188 |
| PFIZER INC. | 13 | $186 |
| Novartis Pharmaceuticals Corporation | 7 | $167 |
| Lilly USA, LLC | 7 | $161 |
| Boston Scientific Corporation | 1 | $111 |
Products named: Leqembi, TYSABRI, Briviact, QULIPTA, INGREZZA, VYEPTI, NURTEC ODT, UBRELVY.
Industry payments across OH — which companies pay providers there.
